Antibodies
|
No. of cases (%)
| |
---|
|
BSCC
|
PDSCC
|
W/MSCC
|
p value*
|
---|
E-cadherin
| | | | | | | |
Weak immunostaining
|
15
|
88.2
|
21
|
80.8
|
15
|
53.6
|
.019
|
Strong immunostaining
|
2
|
11.8
|
5
|
19.2
|
13
|
46.4
|
β-catenin
| | | | | | | |
Weak immunostaining
|
10
|
58.8
|
20
|
76.9
|
20
|
71.4
|
.355
|
Strong immunostaining
|
7
|
41.2
|
6
|
23.1
|
8
|
28.6
|
Total
|
17
|
100
|
26
|
100
|
28
|
100
| |
- Abbreviations: BSCC basaloid squamous cell carcinoma, PDSCC poorly differentiated squamous cell carcinoma, W/MSCC well to moderately differentiated squamous cell carcinoma.
- *Analysis by chi-square test at 5% significance level.